Journal article
How current assay approval policies are leading to unintended imprecision medicine
The lancet oncology, Vol.21(11), pp.1399-1401
11/2020
DOI: 10.1016/S1470-2045(20)30592-1
PMID: 33098760
Abstract
no abstract
Details
- Title: Subtitle
- How current assay approval policies are leading to unintended imprecision medicine
- Creators
- Roberto Salgado - Peter MacCallum Cancer CentreAndrew M Bellizzi - University of IowaDavid Rimm - Yale UniversityJohn M S Bartlett - Ontario Institute for Cancer ResearchTorsten Nielsen - University of British ColumbiaMoch Holger - University of ZurichAnne-Vibeke Laenkholm - Zealand University HospitalCecily Quinn - University College DublinGábor Cserni - University of SzegedIsabela W Cunha - D’Or Institute for Research and EducationIsabel Alvarado-Cabrero - Department of Pathology, Hospital de Oncología, CMN, SXXI, Instituto Mexicano del Seguro Social, Mexico City, MexicoIan Cree - Centre International de Recherche sur le Cancer
- Resource Type
- Journal article
- Publication Details
- The lancet oncology, Vol.21(11), pp.1399-1401
- Publisher
- Elsevier Ltd
- DOI
- 10.1016/S1470-2045(20)30592-1
- PMID
- 33098760
- ISSN
- 1470-2045
- eISSN
- 1474-5488
- Language
- English
- Date published
- 11/2020
- Academic Unit
- Pathology
- Record Identifier
- 9984185277002771
Metrics
25 Record Views